Trends and Outlook of Licensing and M&A in the South Korean Pharmaceutical and Biotech Sector

Over the past five years, the South Korean pharmaceutical and biotech sector has emerged as a hotbed for Licensing and Mergers and Acquisitions (M&A) activity, attracting interest from both domestic and international players. Its unprecedented growth is fuelled by a combination of innovation, government support, and market expansion strategies, alongside the strategic need to access advanced technologies and global markets. This white paper provides an in-depth analysis of the key trends, drivers, and notable transactions that have shaped this dynamic sector, and highlights how international companies can benefit from this thriving market.